|
|
|
|
||
Re: Forward Investment Thesis Noted your reference to Wilson at bottom. Here is his/Regenexbio FDA advisory committee 2021 presentation. Note the IV vs CSF admin. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.fda.gov/media/152000/download ASGCT reference their work with a slide on capsid vs transgene impact. consistent with views about dose level |
return to message board, top of board |